The 2026 Leadership Cash Retention Program triggers significant payouts for four senior executives, led by Chief Executive Officer Richard Paulson, who is set to receive more than $1.7 million. Other recipients include Chief Medical Officer Reshma Rangwala at $725,000, Chief Development Officer Stuart Poulton at $640,000, and Chief Financial Officer Lori Macomber at $625,000.
In section Market Quotes
Karyopharm Shares Drop Following Executive Retention Payouts
Investors pushed Karyopharm Therapeutics stock down 21% in after-hours trading Friday, reacting to the company's disclosure of a new cash-retention program for its top leadership. The sharp decline erased earlier gains, pulling the share price to $7.50 just hours after the firm finalized its regulatory filing with the SEC.
Karyopharm maintains that these awards are necessary to stabilize its core team during an upcoming stretch of critical corporate milestones. In its filing, the company stated that retaining experienced leadership is vital as it prepares for several meaningful catalysts ahead. Despite the market's negative reaction, the stock had previously enjoyed a 29% climb throughout the year prior to the announcement.
Comments (0)
No comments yet. Be the first!